Efficacy of Chitosan gel mucoadhesive containing Doxycycline associated or not to Meloxicam as adjuvant to treatment of gingivitis in dogs with periodontal disease
ABSTRACT. Silva R.C.C., Campos D. R., Oliveira P., Laguna A.G.V., Magalhães V.S., Cid Y.P., Almeida M.B., Scott F.B. & Fernandes J.I. [Efficacy of Chitosan gel mucoadhesive containing Doxycycline associated or not to Meloxicam as adjuvant to treatment of gingivitis in dogs with periodontal disease.] Eficácia de um gel de Quitosano Mucoadesivo contendo Doxiciclina associada ou não ao Meloxicam como coadjuvante ao tratamento da gengivite em cães portadores de doença periodontal. Revista Brasileira de Medicina Veterinária, 38(Supl.2):40-44, 2016. Programa de Pós-Graduação em Medicina Veterinária, Universidade Federal Rural do Rio de Janeiro, BR 465 Km 7, Seropédica, RJ 23897-000, Brasil. E-mail: email@example.com Periodontal disease is the highest occurrence condition in the pet clinic, affecting mainly older animals because of its characteristic of chronicity. Among the clinical signs observed in afflicted animals, gingivitis is the first to be observed. The goal of this study was to develop a mucoadhesive gel, containing doxycycline and meloxicam, and evaluate its efficacy as an adjuvant in the treatment of gingivitis induced by periodontal disease, with a clinical and histopathological rating. Eighteen Beagle dogs presenting gingivitis secondary to periodontal disease were divided into three experimental groups. Group I – animals treated with placebo formulation. Group II – Animals treated with a chitosan gel formulation containing doxycycline. Group III - Animals treated with a chitosan gel formulation containing doxycycline and meloxicam. All animals were treated for seven days, every twelve hours, in the gingival margin of the right maxilla. During the clinic evaluation, only the animals treated with the product containing doxycycline had improved. Contrasting, in the histopathologic evaluation, only animals treated with association of doxycycline and meloxicam presented improvements in their clinical score, although no statistic significance was observed between the groups. The developed formulations were not effective as adjuvants in the treatment of gingivitis induced by periodontal disease treatment.
Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License (CC BY-NC 4.0), allowing the sharing of work with acknowledgement of the authorship of the work and initial publication in this journal. They may take additional contracts separately, with acknowledgement of authorship and initial publication in this journal. They are authorized to publish and distribute their work online after publication by BJVM.
The AUTHOR is informed and agrees with the journal that, therefore, its article may be incorporated into existing databases and scientific information systems (indexers and current databases) or existing in the future (indexers and future databases), under the conditions defined by the latter at all times, which shall at least involve the possibility that the holders of these databases may perform the following actions on the article: Reproduce, transmit and distribute the article, in whole or in part in any form or means of electronic transmission existing or developed in the future, including electronic transmission for research, viewing and printing purposes; extract figures, tables, illustrations, and other graphic objects, and capture metadata, captions, and related articles for search, preview, and print purposes. Scan and/or store images and electronic article text.